Drupal.behaviors.print = function(context) {window.print();window.close();}>
Novartis MDx Focuses on Companion Dx as Key Strategic Direction
December 01, 2011
Novartis MDx Focuses on Companion Dx as Key Strategic Direction
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Novartis Adds Companion Dx to Lumiracoxib Resubmission in Europe
February 4, 2010 / GenomeWeb Daily News
Abbott to Develop Companion Dx for Epizyme Cancer Drug Candidate
April 18, 2013 / GenomeWeb Daily News
Oxford Cancer Biomarkers Developing CDx Biomarkers for AstraZeneca
April 16, 2013 / GenomeWeb Daily News
Foundation Medicine to Develop Dx for Agios Cancer Therapeutics
April 4, 2013 / GenomeWeb Daily News
Myriad, PharmaMar Enter CDx Agreement for HRD Test
March 27, 2013 / GenomeWeb Daily News